Posted by Ellen on November 02, 2001 at 14:47:28:
Want to send this story to another AOL member? Click on the heart at the top of this window.
Advances In Technology: Roche Diagnostics Co-sponsors Diabetes Technology Meeting
Meeting to Showcase Advanced Development of Technology for People with
Diabetes
SAN FRANCISCO, Nov. 2 /PRNewswire/ -- Roche Diagnostics, one of the world's leaders in diabetes technology, is co-sponsoring the first national Diabetes Technology Meeting, which is being held November 2nd and 3rd in San Francisco at the San Francisco Airport Marriott Hotel. The meeting will feature top scientists and clinicians, who will provide information and insight into the latest advances in technology for people with diabetes through lectures, abstract presentations and panel discussions.
"In addition to its current portfolio of blood glucose monitors and other diabetes management tools, Roche Diagnostics is aggressively investing in research and development into technologies designed to help make living with diabetes a little easier," said Manfred Ganz, M.D., director of Medical Assessment for Roche Diagnostics. "Roche Diagnostics is developing minimally and non-invasive technologies for diabetes detection, spot testing and continuous glucose monitoring systems, as well as an automated pancreas, which links artificial intelligence, glucose monitoring and insulin dosing."
Topics Roche Diagnostics is scheduled to present and/or discuss include:
- components of artificial pancreas technology
- alternative site testing as a blood glucose testing option
People with type 1 and type 2 diabetes rely on blood glucose meters and other technologies to manage their disease. Proper disease management can help prevent or delay the onset of complications. Roche Diagnostics' current portfolio of meters includes the Accu-Chek Compact, Accu-Chek Active and Accu- Chek Voicemate, which are designed to provide users with features specific to their needs. For example, Accu-Chek Voicemate provides results orally to people with diabetes who are visually impaired. Accu-Chek Compass software gives people with diabetes and their healthcare providers the ability to analyze blood glucose readings over time.
Roche, a leader in diabetes care, continues its focus on meeting the needs of people with diabetes through its research, technologies, services and the Accu-Chek family of products. Additional products and services in the Accu- Chek family of products include: Accu-Chek Advantage, Accu-Chek Camit Pro, Accu-Chek.com and the Accu-Chek Springboard Module.
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-oriented healthcare groups in the fields of pharmaceuticals, diagnostics and vitamins. Roche's products and services address prevention, diagnosis and treatment of diseases, thus enhancing people's well being and quality of life. Roche's Diagnostics Division supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide.
Accu-Chek, Accu-Chek Advantage, Advantage, Active, Camit, Compact and Compass are trademarks of a Member of the Roche Group.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X15914048
SOURCE Roche Diagnostics
CO: Roche Diagnostics
ST: California, Switzerland
IN: HEA
SU: